We have been uniting the injectable and combination products community for more than a decade. As the industry continues to evolve, we strive to ensure fresh content and discussion points to help you overcome your critical device development challenges.
As we emerge from the pandemic, the past 2 years have highlighted novel pipeline with complex injectable formulation, increasing demand for high volume, self-administered device, and the importance of speed-to-market. Coupled with the fast-evolving regulatory expectations and tightened product quality scrutiny, including EU MDR and the more recent FDA’s EPR guidance, drug and device teams must unite and collaborate to ensure a compliant, robustly validated injectable device with product development integrated.
Be part of the 12th Injectables Summit – a flagship meeting dedicated for senior Parenteral Drug & Device Engineering, Human Factors, Innovations and Regulatory Affairs leaders to share their technical advancements, and together seek solutions to overcome obstacles.
This is the definitive summit to support your timely parenteral drug-device launch with quality, safety and regulatory compliance in mind. Join us this September to engineer the best-in-class combination products for our patients in need!
Supported by industry leaders from Pfizer, Novartis, Takeda, Sanofi and Biogen, we are proud to maintain a peer-led format, showcasing latest case studies across 3 days to help you get inspired, provide best tips to avoid common pitfalls and leave with actionable takeaways.
Supported by industry leaders from Pfizer, Allergan, Eli Lilly, Sanofi and Novo Nordisk, we are proud to maintain a peer-led format, showcasing latest case studies across 3 days to help you get inspired, provide best tips to avoid common pitfalls and leave with actionable takeaways.